Circulating cell-free Epstein-Barr virus DNA measurement for nasopharyngeal carcinoma: advancing towards ctDNA-guided, risk-adaptive individualized treatment.

Copy APA Copied ✓ Copy MLA Copied ✓ Copy BibTeX Copied ✓